Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp137 | Obesity | ECE2019

Empagliflozin as well as Anakinra reduce symptomatic hypoglycemia in patients after Roux-Y-gastric bypass by lowered insulin secretion

Hepprich Matthias , Wiedemann Sophia , Schelker Benjamin , Starkle Alessandra , Trinh Beckey , Boni-Schnetzler Marianne , Rudofsky Gottfried , Donath Marc

Background: Postprandial hypoglycemia is an increasingly recognized complication after bariatric surgery. Its hallmark is a pronounced glycemic rise after carbohydrate ingestion followed by an exaggerated hyperinsulinemic response. Recent studies have shown that IL-1β contributes to postprandial stimulation of insulin. Furthermore, inhibition of SGLT2 reduces excessive plasma glucose increase. Therefore, we investigated whether inhibition of IL-1β with the IL-1 recep...

ea0063p309 | Reproductive Endocrinology 1 | ECE2019

Ano-genital distance in children born of mothers with polycystic ovary syndrome – Odense Child Cohort

Glintborg Dorte , Jensen Richard Christian , Schmedes Anne Vibeke , Brandslund Ivan , Kyhl Henriette Boye , Nielsen Tina Kold , Andersen Marianne Skovsager

Background: Higher testosterone levels during pregnancy in women with polycystic ovary syndrome (PCOS) could be associated with longer offspring ano-genital distance (AGD).Aims: To compare AGD between offspring of mothers with PCOS and controls and to determine possible associations between maternal 3rd trimester testosterone levels and offspring AGD at three months of age.Methods: The study was part of the prospective s...

ea0070oc9.6 | Reproductive and Developmental Endocrinology | ECE2020

Testosterone replacement therapy of opioid induced male hypogonadism improved body composition but not pain perception A double-blinded, randomized and placebo-controlled trial

Glintborg Dorte , Bjarke Vægter Henrik , Lehmann Christensen Louise , Bendix Emma , Graven-Nielsen Thomas , Andersen Per Grunwald , Andersen Marianne

Background: Hypogonadism is prevalent during opioid treatment, but the effect of testosterone replacement treatment (TRT) on body composition, pain perception, and adrenal function is unclear.Purpose: To measure changes in body composition, pain perception, quality of life and adrenal function after TRT or placebo in opioid treated men with chronic non-malignant pain.Methods: Double-blinded, placebo-controlled study in 41 men (&#62...

ea0070aep777 | Pituitary and Neuroendocrinology | ECE2020

Acromegaly is associated with reduced socioeconomic status and more so in female patients: A nationwide population-based study

Dal Jakob , Nielsen Eigil H , Feldt-Rasmussen Ulla , Andersen Marianne , Feltoft Claus , Vestergaard Peter , Stochholm Kirstine , Otto Jorgensen Jens

Context: Acromegaly is a rare and insidious disease associated with severe somatic morbidity but data on socioeconomic status are scarce.Objective: To study the socioeconomic status in acromegaly in a population based, nationwide follow-up study.Patients and Methods: All incident cases of acromegaly (n = 576) during the period 1997–2010 were included, representing 10.116 years at risk. For every patient, 100 pers...

ea0032s23.3 | Endocrine disruptors (Supported by <ulink url="http://www.endocrineconnections.com"><emphasis role="italic">Endocrine Connections</emphasis></ulink>) | ECE2013

Are structural analogs to bisphenol A a safe alternative?

Rosenmai Anna Kjerstine , Taxvig Camilla , Vinggaard Anne Marie , Dybdahl Marianne , Petersen Gitte Alsing , Pedersen Jens Hojslev , Pedersen Mikael

Bispenol A (BPA) is a chemical often integrated in impact-resistant plastics and surface coatings in canned foods as well as screw-on caps and cashier receipts. BPA is either intentionally added or appear as a consequence of recycling in materials with food contact, which leaves consumers at risk of exposure. BPA has known endocrine disrupting effects and is suspected to be a contributing factor in disorders such as overweight, diabetes, cardiovascular diseases, and behavioral...

ea0032p9 | Adrenal cortex | ECE2013

Insulin sensitivity in patients with Addison's disease: a randomised cross-over trial comparing conventional glucocorticoid replacement therapy with continuous subcutaneous hydrocortisone infusion therapy.

Bjornsdottir Sigridur , Nystrom Thomas , Isaksson Magnus , Oksnes Marianne , Husebye Eystein , Lovas Kristian , Kampe Olle , Hulting Anna Lena , Bensing Sophie

Background: Conventional glucocorticoid replacement therapies result in unphysiological variation in plasma cortisol levels; concern has been raised regarding long-term metabolic consequences. Glucocorticoid replacement is technically feasible by continuous subcutaneous hydrocortisone infusion (CSHI), which can mimic the normal diurnal cortisol rhythm. The aim of this study was to compare insulin sensitivity in patients with Addison’s disease (AD) on CSHI vs three daily d...

ea0029p1060 | Male Reproduction | ICEECE2012

Testosterone replacement therapy: A comparison of testosterone mixed esters, extended release testosterone implants and testosterone undecanoate depot

Conaglen Helen M. , Yarndley Tania , Kamp Jozef , Paul Ryan G , Nirmalaraj Kingsley , Elston Marianne S , Conaglen John V

Introduction: Male hypogonadism is one of the most common endocrine disorders affecting 5.6% of men aged between 30–79 years. Testosterone deficiency (TD) is an independent risk factor for multiple cardiovascular risk factors including obesity, diabetes mellitus, hypertension, dyslipidaemia and endothelial dysfunction. The aims of testosterone replacement treatment (TRT) in hypogonadism are to improve or ameliorate the clinical features and to restore the serum T to physi...

ea0014p231 | (1) | ECE2007

Pioglitazone treatment significantly decreases 5-alpha reductase activity and improves metabolic risk factors in PCOS

Glintborg Dorte , Hermann Anne Pernille , Hagen Claus , Veldhuis Johannes , Schmedes Anne , Frystyk Jan , Flyvbjerg Allan , Andersen Marianne

Objective: To investigate the effect of pioglitazone on cortisol metabolism in PCOS.Design: Thirty insulin resistant PCOS patients were randomized to either 16 weeks of pioglitazone (30 mg/day) or placebo treatment. Before and after intervention, patients underwent 24 h 20 min.-integrated blood sampling for measurement of cortisol and 24 h excretion of cortisol, cortisone and steroid metabolites (cortisol, corticosteron, androgen, and 17-hydroxyprogester...

ea0056p335 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Study of the association of transcription factor 7 like 2 gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy in the Egyptian population

Alnaggar Alshaimaa Rezk , El-salam Randa Fayez Abd , Rady Normeen Hany , Ishak Marianne Fathy , Ammar Soha Hamed

Background: Studies from different parts of the world have given controversial results regarding the association of transcription factor 7like 2 (TCF7L2) gene polymorphism with Type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). Aim: This study aimed to investigate if TCF7L2 gene polymorphism, rs12255372(G>T) is a risk factor for the development of T2DM and DN in type 2 Egyptian diabetic patients. PATIENTS AND METHODS: This study was conducted ...

ea0094op3.2 | Reproductive Endocrinology | SFEBES2023

Abnormal uterine bleeding (AUB) and COVID-19: investigating associations and potential mechanisms

Watters Marianne , Alvergne Alexandra , Walker Catherine , Robb Cara , Critchley Hilary , Kountourides Gabriella , Austin Argentieri , Sharp Gemma , Olszewska Zuzanna , Maybin Jacqueline

Women with COVID-19 and Long COVID (symptoms >4 weeks) have reported AUB. We investigated (i) the association between COVID-19/Long COVID and AUB and (ii) ovarian sex hormones across the menstrual cycle in women with Long COVID. Two studies were completed with ethical approvals and consent. Firstly, a retrospective online survey ‘The Covid-19 Pandemic and Women’s Reproductive Health’ was conducted March-May 2021 with UK participants >18 years old (n<...